Category: People

Chainsmokers among Highest Paid DJs in the World

Alex Pall and Andrew Taggart are the faces behind the dynamic duo that make up the infamous Chainsmokers. The two, Alex Pall with experience as a DJ, and Andrew Haggart as a producer met through their manager and have since grown to be among the top-earning Electronic Dance Music groups in America.

The year 2018 has been a good season for the duo, outsmarting their peers in the industry like Steve Aoki, David Guetta, and Diplo. “Closer” and “Something Just Like This” as produced by the Chainsmokers has attracted many fans. As the duo’s fan base keeps expanding, there is even more optimism within their cycles. Currently, the Chainsmokers have an active three-year residency deal with Wynn Nightlife and collect nightly checks of hundreds of thousands of dollars.

In 2017, the duo released their debut album titled “Memories-Do Not Open” which has since achieved platinum status topping the Bill Board album charts.

Currently, Forbes places Chainsmokers at the second place in the list of the World’s highest-earning DJs. At $45.5 million of total earnings for 2018, they are the envy of peers. The future looks even brighter for the pair that has over the years dedicated their time and efforts towards creating EDM that their fans can relate to, and that which transcend culture, race, age, and gender.

Alex and Andrew at 32 and 28 years respectively, have several years ahead of them to excel in their career. The duo is keen to keep with the pace of changes and emerging trends in the music industry. Brainstorming and experimentation of ideas are crucial to their strategy of producing music that is fresh, relevant and interesting to their fans.

The New York-based Chainsmokers has several awards to its name, including a Grammy Award in the category of Best Dance Recording.

It pays to have vision and ambition. Utilizing their talent and passion, Alex Pall and Andrew Haggart, Chainsmokers’ duo, have made a name for themselves and built a brand in an otherwise considered ‘hard to penetrate’ genre in the music industry.

https://www.interviewmagazine.com/music/the-chainsmokers

Renovia Inc. to continue with production of pelvic disorder products under the direction of Marc Beer after the success of Series B round funding

Urinary incontinence is just an example of some of the pelvic disorders that millions of women across the world have had to bear with, in the past decades. However, there is now a light at the end of the tunnel, after Renovia Inc. a Boston based pharmaceutical company announced its plans to continue with the production of various pelvic floor disorder medications. This announcement came after it successfully closed its Series B round funding with $32 million in funding and another $10 million in venture debt.

 

The success of the series B round funding can be attributed to the fact that it’s first pelvic disorder product, dubbed Leva managed to gain FDA approval and is doing pretty well since it entered the market in April. Some of the companies which took part in Series B round include the renowned healthcare investment firm, Longwood fund.

 

Commenting on the matter, Renovia Inc’s Chief executive officer, Marc Beer said that through the support of Longwood Fund, Renovia’s vision will now turn into reality as both companies share the same concept, which is; improving the lives of millions of women across the world who suffer silently due to pelvic disorders. He further added that besides sharing the same vision, both Renovia and Longwood Fund boast top-shelf sensor technologies and all the resources relevant to the project. In respect to this, it will now be possible for them to provide valuable treatment options to their clientele and at the same time create easy access to pelvic disorder information hence enable the patients and the affected gain a deeper understanding of these disorders. According to Marc Beer, this will go a long way in cutting the long-term health care costs associated with conditions such as Urinary incontinence among many other pelvic disorders.

 

 

Longwood’s funding in Series B round will go a long way in enabling Renovia to come up with better products for the diagnosis and treatment of pelvic disorders as it will allow renovia to gain access to all the resources it requires for the development and testing of new products. Some of the products that Renovia aims at bringing forth include a more enhanced, new era Leva device.

 

More about Marc Beer

 

Marc Beer boasts a career that spans over two decades in the biotechnology and healthcare arena. He has worked with various top level pharmaceutical and biotechnology firms where he served the role of Chief Executive officer before moving to another biotech firm known as ViaCell where he was the founding CEO. Marc Beer boasts exemplary leadership skills and this is proved by the fact that every company that he has ever been part of, now rides high on success. For instance, while at Viacell, Marc managed to broaden its horizons and just five years after its inception, the company had increased the number of staff to 300 and even went public. There is no doubt that under his belt, Renovia Inc. which he co-founded with Yolanda Lorie and Ramon Iglesias two years ago, is headed in the same direction. Learn more : https://www.slideshare.net/MarcBeer

No Comments

Categories: Entrepreneurs Finance People

End Citizens United Plans to Make a Difference in 2018 Midterms

Midterm elections are notoriously hard to get people interested in. However, midterm elections are some of the most important elections in the country. This is particularly true as 2018 gets going after a disastrous first year from the Trump administration. The 2018 Midterms have the potential to completely change the political landscape for the next two years, at least. End Citizens United is a political action committee that has committed themselves to getting out and advocating for voters to make their voices heard. End Citizens United was founded on the idea of getting rid of the 2010 Supreme Court ruling surrounding Citizens United — a right-wing propaganda group led by lawyer James Bopp. End Citizens United sees a chance to make serious headway in 2018, and here is how they are going to do it, and what End Citizens United knows.

The 2018 Midterms will likely make or break the entire Trump presidency, though some would argue that it has already been pretty broken as it is. With that being said, things could undergo dramatic change if progressives manage to retake the House and don’t think for a moment that conservatives don’t understand this. End Citizens United is going to spend the next year helping to funnel voters to where they need to go in order to help champion politicians who are willing to fight back for the average American voter. End Citizens United will be directing much of their focus on four vulnerable seats in California. These four seats belong to Dana Rohrabacher, who was alleged to be ‘bought by Putin’ according to Paul Ryan, Darrell Issa and Duncan Hunter, who both are under fire for misusing campaign funds, and Mimi Walters.

https://www.youtube.com/channel/UCnpLmnN_7TxPdpGODs-JXxg

End Citizens United was created in 2015 as a response to the disastrous Citizens United ruling that we’ve spent so much time discussing. The Citizens United ruling fundamentally opened the floodgates to an influx of dark money, special interests, and corporate donors. With this happening, the American government ended up completely hijacked by people with the biggest checks to write. As a result, American voters are increasingly getting ignored by their elected representatives. 2018 shows the first real chance that American voters have to make a difference and start to take back some control of their political voice.

Tiffany Muller is the president of End Citizens United and she has been both vocal and energized in her pursuit for change in Washington D.C. Muller points to California as a real opportunity and she let reporters know that via a conference call. Muller said, “California represents some of the best opportunities, and some of the most egregious examples that we have seen.” Muller is, of course, talking about examples revolving around special interests buying off politicians in the government, and more information click here.

No Comments

Categories: People Politics

Find Out How Scott Rocklage Got Three Drugs Approved by Food and Drug Administration

Dr. Scott Rocklage is a healthcare specialist with over 30 years’ experience in the industry. In 2003, Dr. Rocklage joined 5AM Ventures as a Partner and became a Managing Partner in 2004. Dr. Rocklage got his idea of 5AM Ventures from the “early” concept as 5AM timing is early.

Dr. Rocklage’s extensive experience in healthcare management coupled with his unmatched leadership responsibilities saw Food and Drug Administration (FDA) successfully approve three New Drug Application in the United States. They include Omniscan, Teslascan, and Cubicin. Dr. Rocklage also enrolled six candidates to clinical trials.

Career history

Prior to being a partner at 5AM Ventures, Dr. Rocklage served as the President and CEO of Nycomed Salutar from 1990 to 1994. Dr. Rocklage also served as the Chairman and CEO of Cubist Pharmaceuticals from 1994 to 2003. Dr. Rocklage also held the position of President, CEO, and Chairman of Nycomed Interventional. He has also held several R&D responsibilities at Salutar and Catalytica, served as Chairman of the Board for Relypsa (NASDAQ: PULM) and Novira. He’s currently the Board Chairman of Rennovia, Kinestral, and Cidara (NASDAQ: CDTX) and Epirus (NASDAQ: EPRS) and Pulmatrix (NASDAQ: PULM).

Education background

Dr. Rocklage studied Bachelor of Science in Chemistry from the University of California, Berkeley and did his Ph.D. in Chemistry too from the Massachusetts Institute of Technology. Dr. Rocklage conducted his research in the laboratory of 2005 Chemistry Nobel Prize winner Richard R. Schrock.

Dr. Rocklage who is based in Boston, MA, is an inventor and co-inventor. He holds over 30 U.S. patents and his publications are peer-reviewed more than 100 times.

Dr. Rocklage works with entrepreneurs to brainstorm ideas to life. He actively engages with scientists, physicians, and successful business people in brainstorming on ideas that can bring solutions to unmet medical needs.

Being organized makes Dr. Rocklage more successful as an entrepreneur. He’s never afraid of taking measured risks. Staying true to his business is one strategy that has helped his business grow. Dr. Rocklage advocates that even in hard times, businesses should not stray from their strengths. He advises businesses that if they do hire wrong people who are not making significant contribution to their businesses, they should quickly move on and not be convinced that tracking the individual’s performance record will change them.

Learn more here: http://www.thestylemaponline.com/the-amazing-career-of-scott-rocklage-of-5am-ventures/

No Comments

Categories: People Philanthropy Scientist